Table II.
Cell lines | PT | PN | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
KYSE30 | KYSE410 | KYSE520 | T5 | T6 | T7 | T8 | N2 | N4 | N5 | N6 | |
HSPB2 | M | M | M | M | M | M | M | U | U | U | U |
LOC254531 | M | M | M | M | M | U | U | U | U | ||
ARFRP1 | M | M | M | M | M | M | U | U | |||
KCNMA1 | M | M | M | M | M | U | U | ||||
ARHGAP4 | M | M | M | M | M | M | M | U | U | U | U |
HBA2 | M | M | M | M | U | U | M | U | U | U | U |
HPN | M | M | M | M | M | M | M | ||||
TNNI1 | M | M | M | M | M | M | M | ||||
DFKZP564008232 | U | U | U | U | U | U | U | U | U | U | |
SECTM1 | U | U | U | U | U | U | U | U | U | U | |
WDRX1 | U | U | U | U | U | U | U | U | U | U | |
ABHD2 | U | U | U | U | U | U | U | U | U | U | |
NELL2 | U | U | U | U | U | U | U | U | U | U | U |
SMPD2 | U | U | U | U | U | U | U | U | U | U | U |
COROA1 | U | U | U | U | U | U | U | U | |||
MXD4 | U | U | U | U | U | U | U | U | U | U | U |
DTR | U | U | U | U | U | U | U | U | U | ||
VIM | U | U | U | U | U | U | U | U | U | U | U |
IGFBP7 | U | U | U | U | U | U | U |
M, methylated; U, unmethylated. PN, normal esophageal mucosa collected from ESCC patients; PT, ESCC tissues. Note, HSPB2 methylaton was examined in the region 1 of the promoter.